Decreased risk of HIV-associated TB during antiretroviral therapy expansion in rural Eswatini from 2009 to 2016: a cohort and population-based analysis

scientific article published on 07 August 2019

Decreased risk of HIV-associated TB during antiretroviral therapy expansion in rural Eswatini from 2009 to 2016: a cohort and population-based analysis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/TMI.13290
P932PMC publication ID6852273
P698PubMed publication ID31310029

P50authorAndrew BoulleQ53680127
Michael SchomakerQ56517250
Barbara RuschQ117269827
Iza CigleneckiQ117269828
P2093author name stringWelile Sikhondze
Bernhard Kerschberger
Alex Telnov
Lorraine Pasipamire
Debrah Vambe
Nicholas Kisyeri
Siphiwe Mavis Ngwenya
P2860cites workXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsQ24200879
Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysisQ26798435
A systematic review of published literature describing factors associated with tuberculosis recurrence in people living with HIV in AfricaQ28387848
Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South AfricaQ28533713
Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South AfricaQ28547001
Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysisQ28657913
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyQ29615717
Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysisQ30245603
Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013.Q30378028
The rise and fall of tuberculosis in Malawi: associations with HIV infection and antiretroviral therapy.Q30385976
Sexual inequality in tuberculosisQ33520199
Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resourcesQ42977188
The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan settingQ44674242
Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.Q47121800
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy studyQ47202008
Recent advances in tuberculosis diagnostics in resource-limited settings.Q52575510
The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era.Q52623018
Challenges and successes in the implementation of option B+ to prevent mother-to-child transmission of HIV in southern Swaziland.Q52646486
Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural MalawiQ62494420
Tuberculosis decline in populations affected by HIV: a retrospective study of 12 countries in the WHO African RegionQ64357339
Programmatic outcomes and impact of rapid public sector antiretroviral therapy expansion in adults prior to introduction of the WHO treat-all approach in rural EswatiniQ92777740
A re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan AfricaQ33813159
Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the communityQ34222186
Antiretroviral therapy for tuberculosis control in nine African countriesQ34320245
Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysisQ34387168
Tuberculosis recurrence in a high incidence setting for HIV and tuberculosis in BrazilQ34429881
The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after studyQ34447727
Migration and AIDS.Q34892196
Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosisQ34999621
Recent patterns in population-based HIV prevalence in SwazilandQ35021677
Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in SwazilandQ35103348
Implementation and Operational Research: Barriers and Facilitators to Combined ART Initiation in Pregnant Women With HIV: Lessons Learnt From a PMTCT B+ Pilot Program in SwazilandQ35566705
Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis.Q35584415
Completeness and Reliability of the Republic of South Africa National Tuberculosis (TB) Surveillance SystemQ35741687
Declining tuberculosis notification trend associated with strengthened TB and expanded HIV care in SwazilandQ35805029
The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort studyQ35846261
Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South AfricaQ35850330
Potential impact of multiple interventions on HIV incidence in a hyperendemic region in Western Kenya: a modelling studyQ36003735
Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysisQ36096194
Outcomes of TB treatment in HIV co-infected TB patients in Ethiopia: a cross-sectional analytic studyQ36183133
Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trialQ36246188
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatmentQ36424963
Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapyQ36514050
High mortality in tuberculosis patients despite HIV interventions in SwazilandQ37020503
Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, MalawiQ37023865
Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South AfricaQ37240761
Antiretroviral therapy and TB notification rates in a high HIV prevalence South African communityQ37240770
Declining tuberculosis case notification rates with the scale-up of antiretroviral therapy in ZimbabweQ37279224
Five years retrospective cohort analysis of treatment outcomes of TB-HIV patients at a PEPFAR/DOTS Centre in South Eastern NigeriaQ37418344
Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impactQ37514147
Possible misdiagnosis of HIV associated lymphoma as tuberculosis among patients attending Uganda Cancer InstituteQ37700895
Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.Q38855709
Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time series analysisQ38991491
Multiple imputation using chained equations: Issues and guidance for practiceQ39513291
Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventionsQ39747436
P433issue9
P921main subjectEswatiniQ1050
P304page(s)1114-1127
P577publication date2019-08-07
P1433published inTropical Medicine and International HealthQ15765747
P1476titleDecreased risk of HIV-associated TB during antiretroviral therapy expansion in rural Eswatini from 2009 to 2016: a cohort and population-based analysis
P478volume24